In summary, our results provide new information supporting the already well-established tumour suppressor role of HIPK2, and also could explain how under certain conditions (for example, cancer cell chemoresistance due to upregulated NRF2) HIPK2 might provide cancer cells with a survival advantage. This evidence concerns the gene NFE2L2 and cancer.